In view of increased frequencies of Th22 cells in L-MDS and Th17 cells in E-MDS, we also determined the mRNA expression levels of regulatory factors IL-6, TNF-α and IL-23 in MDS patients and controls. This evidence concerns the gene TNF and myelodysplastic syndrome.